Late Stage: Phase IIb-III Clinical Trials

As studies become more complex, Fortrea brings the experience and innovations needed to minimize delays and mitigate risks.

Fortrea is a knowledge-driven clinical research partner with global trial experience in more than 55 countries.

Our comprehensive suite of services fulfills any global clinical trial need, from protocol development to data lock and submissions.

One size does not fit all.

When the stakes are high, you need an experienced end-to-end partner. You're not merely looking for experts; you want the right team for each study. We provide a seasoned project management team with scientific and therapeutic expertise relevant to your specific study needs. With your product’s future on the line our approach ensures that your projects are delivered within timeline, data quality and budgetary targets.

Global planning, local optimization.

Before the goal of regulatory approval is in sight, you need to navigate a global maze of diverse patient populations, practice patterns, regulatory requirements, languages and time zones, among others. These challenges require a broad range of trusted resources.

You won't do it alone. Fortrea offers a comprehensive suite of clinical phase IIb/III services — all supported by purpose-built technologies to keep your study on track and improve your ROI.

  • Xcellerate® Clinical Trial Optimization®
  • Clinical Trial Management System (CTMS)
  • Endpoint IXRS

Enhanced patient recruitment.

Fortrea will help you find the most appropriate study locations and the most qualified investigators to support target patient enrollment populations. Our proprietary informatics database means you can engage investigators more likely to help you meet your patient enrollment goals from the start.

With a global network of sites and solutions to drive diversity and inclusion in clinical trials, and protocol designs that incorporate our Voice of the Patient program, we develop clinical trial strategies that can be achieved with patients motivated to participate.

Out of pocket, out of mind.

Investigator out-of-pocket costs can make up almost half of a total study budget. Fortrea’s global processes deliver efficient, timely and accurate invoicing, which helps you stay within +/- 3 percent of your planned budget more than 90 percent of the time.

Stay up to date:
Subscribe for Fortrea news & announcements.